DMD Therapeutics' Grant

DMD Therapeutics raised a round of funding on February 24, 2017.

DMD Therapeutics is a drug developer for Duchenne muscular dystrophy (DMD). Its product DMD-813 has been shown in preclinical studies to reduce damage and inflammation in muscle leading to markedly in…

Articles about DMD Therapeutics' Grant: